Process for hydrogenating ketones in the presence of Ru(II) catalysts
US-9416100-B2 · Aug 16, 2016 · US
US12491503B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12491503-B2 |
| Application number | US-201917291122-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 1, 2019 |
| Priority date | Nov 6, 2018 |
| Publication date | Dec 9, 2025 |
| Grant date | Dec 9, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a novel process for the iridium-catalysed hydrogenation of oximes. The invention also relates to novel iridium catalysts for use in the iridium-catalysed hydrogenation of oximes and to processes of preparation of these catalysts. The invention further relates to the use of the novel iridium catalysts in ionic hydrogenation of other unsaturated substrates.
Opening claim text (preview).
What is claimed is: 1 . A process for the hydrogenation of an oxime of formula (I) to produce a hydroxylamine salt of formula (II) by reacting oxime (I) with hydrogen in the presence of an iridium catalyst of formula (IIIa) or formula (IIIb) and an acid; wherein R 1 , R 2 and R 3 are each independently hydrogen, C 1 -C 8 alkyl, C 1 -C 8 hydroxyalkyl, C 1 -C 8 cyanoalkyl, C 1 -C 6 alkoxyC 1 -C 8 alkyl, di(C 1 -C 6 alkoxy) C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 2 -C 6 alkenyl, C 3 -C 8 cycloalkyl, phenyl, phenylC 1 -C 8 alkyl or heteroaryl, and wherein the cycloalkyl and phenyl moieties are each optionally substituted with 1 to 5 groups selected from hydroxyl, halogen, C 1 -C 6 alkyl, C 3 -C 8 cycloalkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, phenyl, heteroaryl, C 1 -C 6 alkoxycarbonyl, acylamino, amido, cyano, nitro and C 2 -C 6 alkenyl; or R 1 and R 2 together with the carbon atom to which they are attached may form a 4- to 8-membered saturated cycloalkyl or heterocyclyl ring, wherein the heterocyclic moiety is a non-aromatic monocyclic ring which comprises 1, 2 or 3 heteroatoms, wherein the heteroatoms are individually selected from N, O and S; R 6 , R 7 , R 8 , R 9 and R 10 are each independently hydrogen or C 1 -C 3 alkyl; represents a bidentate chelating ligand comprising at least one carbon atom which coordinates to iridium and at least one nitrogen atom which coordinates to iridium; X represents an anionic group of the formula R 14 —SO 2 O— or R 15 —C(O)O—, wherein R 14 is hydroxy, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 haloalkyl, or phenyl, wherein the phenyl moieties are optionally substituted by 1, 2, 3 or 4 substituents, which may be the same or different, selected from R 16 ; R 16 is C 1-4 alkyl, C 1-4 haloalkyl, nitro, or halogen; R 15 is C 1-6 haloalkyl or phenyl, wherein the phenyl moieties are optionally substituted by 1, 2, 3 or 4 substituents, which may be the same or different, selected from R 17 , R 17 is C 1-4 alkyl, C 1-4 haloalkyl, nitro or halogen; Y represents a neutral ligand; and Z represents an anionic group. 2 . The process according to claim 1 , wherein R 6 , R 7 , R 8 , R 9 and R 10 each represent hydrogen or methyl. 3 . The process according to claim 1 , wherein X represents a group of the formula R 14 —SO 2 O − . 4 . The process according to claim 1 , wherein the bidentate chelating ligand is selected from a compound of formula (IV-1), (IV-2), (IV-3), (IV-5), (IV-6), (IV-7), (IV-8), (IV-9), (IV-10), (IV-11) and (IV-12): 5 . The process according to claim 1 , wherein Z is R 14 —SO 2 O − , mesylate, sulfate, hydrogenosulfate, tetrafluoroborate, hexafluorophosphate, tetraphenylborate, or tetrakis(3,5-bis(trifluoromethyl)phenyl)borate. 6 . The process according to claim 1 , wherein the acid is methanesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, sulfuric acid or triflic acid. 7 . The process according to claim 1 , wherein Y is H 2 O or MeCN. 8 . The process according to claim 1 , wherein the iridium catalyst is a compound of formula (III-1), (III-11), (III-17), (III-18), or (III-19): 9 . The process according to claim 1 , wherein the hydroxylamine of formula (II) is N-methoxy-1-(2,4,6-trichlorophenyl) propan-2-amine (II-1). 10 . The process according to claim 9 , wherein N-methoxy-1-(2,4,6-trichlorophenyl)propan-2-amine (II-1) is further reacted with 3-(difluoromethyl)-1-methyl-pyrazole-4-carbonyl chloride (XII) to provide 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]pyrazole-4-carboxamide (XIII):
Metallocenes · CPC title
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms · CPC title
with substituted hydrocarbon radicals attached to ring carbon atoms · CPC title
having oxygen atoms of hydroxylamino groups etherified · CPC title
having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.